Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)
Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –
Nephros net income
Net income is the profit left for shareholders after every expense, interest and tax.
Nephros's net income for the twelve months ending Jun 30, 2026 was $1.74M, up 30.8% year over year. For fiscal 2025 it was $1.19M, up 1513.5% from the year before. The highest annual figure on record is $3.88M in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19M | +1513.5% |
| FY2024 | Dec 31, 2024 | $74.00K | – |
| FY2023 | Dec 31, 2023 | -$1.58M | – |
| FY2021 | Dec 31, 2021 | -$3.87M | – |
| FY2020 | Dec 31, 2020 | -$4.53M | – |
| FY2019 | Dec 31, 2019 | -$3.18M | – |
| FY2018 | Dec 31, 2018 | -$3.40M | – |
| FY2017 | Dec 31, 2017 | -$809.00K | – |
| FY2016 | Dec 31, 2016 | -$3.03M | – |
| FY2015 | Dec 31, 2015 | -$3.09M | – |
| FY2014 | Dec 31, 2014 | -$7.37M | -657.6% |
| FY2013 | Dec 31, 2013 | $1.32M | – |
| FY2012 | Dec 31, 2012 | -$6.62M | – |
| FY2011 | Dec 31, 2011 | -$7.00M | -280.4% |
| FY2010 | Dec 31, 2010 | $3.88M | – |
| FY2009 | Dec 31, 2009 | -$12.08M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.20M | +405.1% |
| Q1 FY2026 | Mar 31, 2026 | $140.00K | -74.9% |
| Q4 FY2025 | Dec 31, 2025 | $62.00K | -82.2% |
| Q3 FY2025 | Sep 30, 2025 | $337.00K | +84.2% |
| Q2 FY2025 | Jun 30, 2025 | $237.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $558.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $349.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $183.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$289.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$169.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$654.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$182.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$433.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$306.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.97M | – |
| Q4 FY2021 | Dec 31, 2021 | -$863.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.13M | – |
| Q1 FY2021 | Mar 31, 2021 | -$537.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$759.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.01M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.66M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$144.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$744.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$942.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.35M | – |
| Q4 FY2018 | Dec 31, 2018 | -$725.00K | -156.2% |
| Q3 FY2018 | Sep 30, 2018 | -$566.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$682.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.43M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$632.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$786.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$680.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$655.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$706.00K | – |
See a number that looks wrong?